Skip to main content
SpringerLink
Log in

Advanced endometrial cancers—outcome of patients undergoing cytoreductive surgery: a retrospective study

  • Original Article
  • Published:
Indian Journal of Gynecologic Oncology Aims and scope Submit manuscript

Abstract

Objectives

The objective of the study was to assess the overall and disease free survival in patients with advanced (Stage III and IV) endometrial cancer who undergo cytoreductive surgery, and to assess the factors affecting recurrence in these patients.

Methodology

80 patients with advanced endometrial cancer who were diagnosed and had undergone surgery in Regional Cancer Center, Thiruvananthapuram between 2008 and 2018 were included. Patients who underwent neoadjuvant chemotherapy or radiotherapy initially and surgery later were also included for analysis.

Results

Mean age was 59.9 yrs. Patients with Stage III disease constituted 81.2% (n = 65) of the population whereas 18.8% (n = 15) had stage IV endometrial cancer. There were 53 patients (66.3%) with endometrioid histology whereas 12 (15%) had serous carcinoma, 6 (7.5%) had clear cell carcinoma and 9 (11.2%) had carcinosarcoma. Majority of the patients, 69 (86.3%) had primary surgery, while 11 (13.7%) had upfront chemotherapy or radiotherapy before surgery. Complete cytoreduction was achieved in 72 (90%) of the patients who underwent surgery. Adjuvant treatment was chemotherapy and radiation was given in 41 patients (51.2%), while 15 (18.8%) received chemotherapy alone and 18 (21.3%) received radiotherapy alone. Median follow up period was 92 months. Relapse occurred in 50 patients (62.5%) and death in 49 patients (61.2%). 5 year DFS was 39% and OS was 46.9%. Factors significantly correlating to recurrence on univariate analysis included age more than 60 years, non endometrioid histology, high grade, LVSI and pelvic nodal metastases. However on multivariate analysis, only non endometrioid histology was found to have a significant correlation with recurrence. Factors significantly correlating to survival were age more than 60 yrs, Pre op Albumin less than 4 g%, non endometrioid histology, high grade, presence of LVSI and site of recurrence in lung and para aortic lymph nodes. However on multivariate analysis, only non endometrioid histology was found to have a significant correlation with survival.

Conclusion

In carefully selected patients with advanced endometrial cancer, a combination of surgical cytoreduction with appropriate adjuvant treatment and neoadjuvant treatment when indicated gives good results with an acceptable morbidity and mortality and reasonable overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article  PubMed  Google Scholar 

  2. Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: result from national cancer registry programme, India. Indian J Med Res. 2022;156(4&5):598–607.

    PubMed  Google Scholar 

  3. Kitchener HC, Trimble EL. Endometrial cancer state of the science meeting. Int J Gynecol Cancer. 2009;19:134–40.

    Article  PubMed  Google Scholar 

  4. Ueda SM, Kapp DS, Cheung MK, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008;198(218):e211-216.

    Google Scholar 

  5. Goff BA. Uterine papillary serous carcinoma: what have we learned over the past quarter century? Gynecol Oncol. 2005;98(3):341–3.

    Article  PubMed  Google Scholar 

  6. Thomas M, Mariani A, Wright JD, et al. Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review. Gynecol Oncol. 2008;108(2):293–7.

    Article  CAS  PubMed  Google Scholar 

  7. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  8. Percorelli S, Pettersson CW, Benedet F, et al. FIGO annual report on the results of treatment in gynecologic cancer. J Epidemiol Biostat. 1998;3(35):35–62.

    Google Scholar 

  9. Shih KK, et al. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol. 2011;122(3):608–11.

    Article  CAS  PubMed  Google Scholar 

  10. Goff BA, et al. Surgical stage IV endometrial carcinoma: a study of 47 cases. Gynecol Oncol. 1994;52(2):237–40.

    Article  CAS  PubMed  Google Scholar 

  11. Lambrou NC, Gomez-Marin O, Mirhashemi R, et al. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol Oncol. 2004;93:653–8.

    Article  PubMed  Google Scholar 

  12. Levine D. The Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27(1):16–41.

    Article  CAS  PubMed  Google Scholar 

  14. Barlin JN, Puri I, Bristow RE. Cytoreductive surgery for advanced endometrial cancer. A meta-analysis. Gynecol Oncol. 2010;118:14–8.

    Article  PubMed  Google Scholar 

  15. Alagkiozidis I, Grossman A, Tang NZ, Weedon J, Mize B, Salame G, Lee YC, Abulafia O. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study. Int J Surg. 2015;14:61–6.

    Article  PubMed  Google Scholar 

  16. Monk BJ, Smith G, Lima J, Long GH, Alam N, Nakamura H, Meulendijks D, Ghiorghiu D, Banerjee S. Real-world outcomes in patients with advanced endometrial cancer: a retrospective cohort study of US electronic health records. Gynecol Oncol. 2022;164(2):325–32.

    Article  PubMed  Google Scholar 

  17. Cancer stat facts : Uterine cancer. Surveillance, Epidemiology and End results program. 2017

  18. Schorge JO, Clark RM, Lee SI, Penson RT. Primary debulking surgery for advanced ovarian cancer: are you a believer or a dissenter? Gynecol Oncol. 2014. https://doi.org/10.1016/j.ygyno.2014.10.007.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, Regional Cancer Centre, Thiruvananthapuram, India

    Dhanya Dinesh, P. Rema & S. Suchetha

  2. Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, India

    J. Sivaranjith

  3. Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, India

    Francis V. James

  4. Department of Epidemiology and Biostatistics, Regional Cancer Centre, Thiruvananthapuram, India

    K. M. Jagathnath Krishna

Authors
  1. Dhanya Dinesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Rema
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Suchetha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Sivaranjith
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francis V. James
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. M. Jagathnath Krishna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dhanya Dinesh.

Ethics declarations

Conflict of interest

The authors hereby declare that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dinesh, D., Rema, P., Suchetha, S. et al. Advanced endometrial cancers—outcome of patients undergoing cytoreductive surgery: a retrospective study. Indian J Gynecol Oncolog 22, 86 (2024). https://doi.org/10.1007/s40944-024-00850-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40944-024-00850-9

Keywords

Search

Navigation